Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures
- PMID: 16302009
- DOI: 10.1038/sj.mp.4001775
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures
Abstract
The gene coding for ubiquilin 1 (UBQLN1) is located near a linkage peak on chromosome 9q22.2 and it also impacts the function of presenilin proteins involved in early-onset Alzheimer's disease (AD). Recently, genetic variation in UBQLN1 has been shown to affect the risk of AD in two independent family-based samples. The purpose of this study was to confirm the reported association in a large case-control sample and to also examine the association of UBQLN1 SNPs with quantitative measures of AD progression, namely age-at-onset (AAO), disease duration and Mini-Mental State Examination (MMSE) score. We examined the associations of three SNPs in the UBQLN1 gene (intron 6/A>C, intron 8/T>C and intron 9/A>G) in up to 978 LOAD cases and 808 controls. All SNPs were in significant linkage disequilibrium (P<0.0001). While modest significant associations were observed in the single-site regression analysis, 3-site haplotype analysis revealed significant associations (P<0.0001 for overall haplotype analysis). One common haplotype (H4) defined by intron 6/A-intron 8/C-intron 9/G alleles was associated with AD risk and one less common haplotype (H5) defined by intron 6/C-intron 8/C-intron 9/A alleles was associated with protection. The adjusted odds ratios with potentially one and two copies of risk haplotype H4 were 1.5 (95% CI: 0.99-2.26; P=0.054) and 3.66 (95% CI: 1.43-9.39; P=0.007), respectively, and odds ratio for haplotype H5 carriers was 0.31 (95% CI: 0.10-0.95; P=0.0398). In addition to disease risk, the homozygosity of the risk haplotype was also associated with older AAO, longer disease duration and lower MMSE score. In summary, our data from a large case-control cohort indicate that genetic variation in the UBQLN1 gene has a modest effect on risk, AAO and disease duration of AD. Our haplotype data suggest the presence of additional putative functional variants either in the UBQLN1 gene or nearby genes and provide strong justification for additional work in this region on chromosome 9.
Similar articles
-
Analysis of UBQLN1 variants in a Polish Alzheimer's disease patient: control series.Dement Geriatr Cogn Disord. 2008;25(4):366-71. doi: 10.1159/000121006. Epub 2008 Mar 14. Dement Geriatr Cogn Disord. 2008. PMID: 18340109
-
The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.Neurosci Lett. 2006 Jan 9;392(1-2):72-4. doi: 10.1016/j.neulet.2005.08.064. Epub 2005 Oct 6. Neurosci Lett. 2006. PMID: 16214290
-
Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.Neurosci Lett. 2007 Aug 31;424(1):1-5. doi: 10.1016/j.neulet.2007.07.015. Epub 2007 Aug 1. Neurosci Lett. 2007. PMID: 17709205
-
Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.Am J Epidemiol. 2005 Aug 15;162(4):305-17. doi: 10.1093/aje/kwi202. Epub 2005 Jul 20. Am J Epidemiol. 2005. PMID: 16033878 Review.
-
Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.Exp Gerontol. 2006 Jan;41(1):85-92. doi: 10.1016/j.exger.2005.10.005. Epub 2005 Nov 16. Exp Gerontol. 2006. PMID: 16297587 Review.
Cited by
-
A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.Neurobiol Aging. 2012 Apr;33(4):804-13. doi: 10.1016/j.neurobiolaging.2010.05.018. Epub 2010 Jun 30. Neurobiol Aging. 2012. PMID: 20580132 Free PMC article.
-
Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.Biochemistry. 2007 Jul 31;46(30):8827-37. doi: 10.1021/bi700604q. Epub 2007 Jul 6. Biochemistry. 2007. PMID: 17614368 Free PMC article.
-
GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95. doi: 10.1016/j.neuropharm.2009.07.027. Epub 2009 Jul 23. Neuropharmacology. 2009. PMID: 19631671 Free PMC article. Review.
-
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.Mol Psychiatry. 2009 Nov;14(11):1004-16. doi: 10.1038/mp.2009.10. Epub 2009 Feb 10. Mol Psychiatry. 2009. PMID: 19204726 Free PMC article.
-
Unraveling the genes implicated in Alzheimer's disease.Biomed Rep. 2017 Aug;7(2):105-114. doi: 10.3892/br.2017.927. Epub 2017 Jun 14. Biomed Rep. 2017. PMID: 28781776 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical